DECK: Non-Endocrine Targeted Treatments for HR+, HER2- MBC
This slide deck provides an overview of non-endocrine, targeted treatment options in HR+, HER2- MBC, including information on the MOA of different therapy classes and the phase 2/3 clinical studies for approved therapies in this setting.
Date of Last Review: April 17, 2024
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice